Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 23 Apr 2023
The treatment of chronic thromboembolic pulmonary hypertension with balloon pulmonary angioplasty has an evolving safety profile over the years, from 2013 to 2022, as revealed by an analysis of more than two dozen studies.
Read Full NewsA viral plastic diet trend raises concerns for choking, metabolic disruption, and increased risk for eating disorders among youth.
Higher intensity of physical activity, regardless of total volume, is linked to significantly lower risks for many cardiovascular and other chronic diseases and death.
1.
TRK Inhibitor Active in Treatment-Refractory Glioblastoma
2.
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease
3.
In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.
4.
Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer
5.
VP Nominee Medical Records Breached; Queen Elizabeth's Cancer; Galaxy Gas Whippets
1.
The New Frontier of Cancer Survivorship: Navigating the Long-Term Effects of Immunotherapy and Targeted Therapies
2.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
3.
Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer
4.
The Capmist DM: A Revolutionary Way to Combat Dry Mouth
5.
Hypercoagulable State: Factors that Contribute to Blood Clots
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
4.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge